Molecular characteristics of travel-related extended-spectrum-β- lactamase-producing Escherichia coli isolates from the Calgary Health Region

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2539-2543

  Pitout, Johann D D ^a,c   Campbell, Lorraine ^a   Church, Deirdre L ^a,b   Gregson, Daniel B ^a,b   Laupland, Kevin B ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CANADA; ENZYME SYNTHESIS; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TRAVEL; URINE;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; FLUOROQUINOLONES; HUMANS; TRAVEL;

EID: 67049173052     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00061-09     Document Type: Article

References (34)

1. Al Naiemi, N., B. Zwart, M. C. Rijnsburger, R. Roosendaal, Y. J. Debets-Ossenkopp, J. A. Mulder, C. A. Fijen, W. Maten, C. M. Vandenbroucke-Grauls, and P. H. Savelkoul. 2008. Extended-spectrum-β- lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. J. Clin. Microbiol. 46:2794-2795.
2. CTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob. Agents Chemother. 49:1319-1322.
3. Cagnacci, S., L. Gualco, E. Debbia, G. C. Schito, and A. Marchese. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612.
4. Cantón, R., and T. M. Coque. 2006. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
5. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Colgan, R., J. R. Johnson, M. Kuskowski, and K. Gupta. 2008. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob. Agents Chemother. 52:846-851.
7. Coque, T. M., A. Novais, A. Carattoli, L. Poirel, J. Pitout, L. Peixe, F. Baquero, R. Canton, and P. Nordmann. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.
8. Ensor, V. M., M. Shahid, J. T. Evans, and P. M. Hawkey. 2006. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. J. Antimicrob. Chemother. 58:1260-1263.
9. Freeman, J. T., S. J. McBride, H. Heffernan, T. Bathgate, C. Pope, and R. B. Ellis-Pegler. 2008. Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clin. Infect. Dis. 47:689-692.
10. Friedman, N. D., K. S. Kaye, J. E. Stout, S. A. McGarry, S. L. Trivette, J. P. Briggs, W. Lamm, C. Clark, J. MacFarquhar, A. L. Walton, L. B. Reller, and D. J. Sexton. 2002. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 137:791-797.
11. Gupta, S. K., F. Medalla, M. W. Omondi, J. M. Whichard, P. I. Fields, P. Gerner-Smidt, N. J. Patel, K. L. Cooper, T. M. Chiller, and E. D. Mintz. 2008. Laboratory-based surveillance of paratyphoid fever in the United States: travel and antimicrobial resistance. Clin. Infect. Dis. 46:1656-1663.
12. Gupta, V., and P. Datta. 2007. Extended-spectrum beta-lactamases (ESBL) in community isolates from North India: frequency and predisposing factors. Int. J. Infect. Dis. 11:88-89.
13. Hawkey, P. M. 2008. Prevalence and clonality of extended-spectrum betalactamases in Asia. Clin. Microbiol. Infect. 14(Suppl. 1):159-165.
14. Hrabák, J., J. Empel, M. Gniadkowski, Z. Halbhuber, K. Rebl, and P. Urbaskova. 2008. CTX-M-15-producing Shigella sonnei strain from a Czech patient who traveled in Asia. J. Clin. Microbiol. 46:2147-2148.
15. Hunter, S. B., P. Vauterin, M. A. Lambert-Fair, M. S. Van Duyne, K. Kubota, L. Graves, D. Wrigley, T. Barrett, and E. Ribot. 2005. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J. Clin. Microbiol. 43:1045-1050.
16. Johnson, J. R., B. D. Johnston, J. H. Jorgensen, J. Lewis II, A. Robicsek, M. Menard, C. Clabots, S. J. Weissman, N. D. Hanson, R. Owens, K. Lolans, and J. Quinn. 2008. CTX-M-15-producing Escherichia coli (Ec) in the United States (US): predominance of sequence type ST131 (O25:H4). Abstr. 48th Intersci. Conf. Antimicrob. Agents Chemother. Washington, DC.
17. Karim, A., L. Poirel, S. Nagarajan, and P. Nordmann. 2001. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201:237-241.
18. Kim, S., J. Hu, R. Gautom, J. Kim, B. Lee, and D. S. Boyle. 2007. CTX-M extended-spectrum beta-lactamases, Washington State. Emerg. Infect. Dis. 13:513-514.
19. Lau, S. H., M. E. Kaufmann, D. M. Livermore, N. Woodford, G. A. Willshaw, T. Cheasty, K. Stamper, S. Reddy, J. Cheesbrough, F. J. Bolton, A. J. Fox, and M. Upton. 2008. UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J. Antimicrob. Chemother. 62:1241-1244.
20. Laupland, K. B., D. L. Church, J. Vidakovich, M. Mucenski, and J. D. Pitout. 2008. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J. Infect. 57:441-448.
21. Mensa, L., F. Marco, J. Vila, J. Gascon, and J. Ruiz. 2008. Quinolone resistance among Shigella spp. isolated from travellers returning from India. Clin. Microbiol. Infect. 14:279-281.
22. Nicolas-Chanoine, M. H., J. Blanco, V. Leflon-Guibout, R. Demarty, M. P. Alonso, M. M. Canica, Y. J. Park, J. P. Lavigne, J. Pitout, and J. R. Johnson. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
23. Pitout, J. D. 2008. Multiresistant Enterobacteriaceae: new threat of an old problem. Expert Rev. Anti. Infect. Ther. 6:657-669.
24. Pitout, J. D., D. L. Church, D. B. Gregson, B. L. Chow, M. McCracken, M. R. Mulvey, and K. B. Laupland. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51:1281-1286.
25. Pitout, J. D., D. B. Gregson, D. L. Church, S. Elsayed, and K. B. Laupland. 2005. Community-wide outbreaks of clonally related CTX-M-14 β-lactamase- producing Escherichia coli strains in the Calgary health region. J. Clin. Microbiol. 43:2844-2849.
26. Pitout, J. D., N. Hamilton, D. L. Church, P. Nordmann, and L. Poirel. 2007. Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in Enterobacteriaceae. Clin. Microbiol. Infect. 13:291-297.
27. Pitout, J. D., and K. B. Laupland. 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166.
28. Pitout, J. D., Y. Wei, D. L. Church, and D. B. Gregson. 2008. Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6′)-Ib-cr. J. Antimicrob. Chemother. 61:999-1002.
29. Robicsek, A., J. Strahilevitz, D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874.
30. Rodrigues, C., U. Shukla, S. Jog, and A. Mehta. 2005. Extended-spectrum beta-lactamase-producing flora in healthy persons. Emerg. Infect. Dis. 11:981-982.
31. Rossolini, G. M., M. M. D'Andrea, and C. Mugnaioli. 2008. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin. Microbiol. Infect. 14(Suppl. 1):33-41.
32. Sannes, M. R., E. A. Belongia, B. Kieke, K. Smith, A. Kieke, M. Vandermause, J. Bender, C. Clabots, P. Winokur, and J. R. Johnson. 2008. Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin. J. Infect. Dis. 197:430-434.
33. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
34. Yumuk, Z., G. Afacan, M. H. Nicolas-Chanoine, A. Sotto, and J. P. Lavigne. 2008. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 62:284-288.